Employees Provident Fund Board’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147M Hold
2,190,029
0.85% 34
2026
Q1
$138M Hold
2,190,029
1.04% 33
2025
Q4
$145M Hold
2,190,029
1.07% 34
2025
Q3
$147M Hold
2,190,029
1.18% 32
2025
Q2
$191M Buy
2,190,029
+312,529
+17% +$24.5M 1.65% 25
2025
Q1
$128M Buy
1,877,500
+107,000
+6% +$8.73M 1.46% 26
2024
Q4
$138M Buy
1,770,500
+832,239
+89% +$61.6M 1.71% 24
2024
Q3
$62.9M Hold
938,261
0.86% 46
2024
Q2
$106M Buy
938,261
+63,246
+7% +$8M 1.7% 20
2024
Q1
$121M Sell
875,015
-110,033
-11% -$13.8M 2.13% 13
2023
Q4
$122M Buy
985,048
+68,207
+7% +$6.97M 2.39% 15
2023
Q3
$85.5M Buy
916,841
+734,915
+404% +$82.8M 1.94% 20
2023
Q2
$23.4M Buy
+181,926
New +$22M 0.55% 45

Other funds holding DXCM

Employees Provident Fund Board's DXCM Position: Q2 2026 in Review

Employees Provident Fund Board held its DexCom (DXCM) position steady in Q2 2026 at 2,190,029 shares worth $147M. The position accounts for 0.85% of the portfolio, ranked #34.

Employees Provident Fund Board first reported a position in DXCM in Q2 2023 and has held it in 13 quarters since. The position peaked at $191M in Q2 2025. 964 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Employees Provident Fund Board held 2,190,029 shares of DexCom worth $147M as of Q2 2026.
  • Employees Provident Fund Board left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.85% of Employees Provident Fund Board's portfolio in Q2 2026, its #34 holding.
  • Employees Provident Fund Board first reported a position in DexCom in Q2 2023 and has held it in 13 quarters since.
  • Employees Provident Fund Board's DexCom position peaked at $191M in Q2 2025.
  • 964 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.